A novel gene panel offered predictive value for first-line treatment of small cell lung cancer with carboplatin, etoposide, and atezolizumab.
The post Novel Gene Panel Facilitates Biomarker-Guided Chemo-Immunotherapy in Extensive-Stage SCLC first appeared on Physician’s Weekly.
